43 results on '"Gjerdrum, Lise Mette Rahbek"'
Search Results
2. Topical Neuropeptide Y for Ischemic Skin Wounds
3. Fatal JC-virus Granular Cerebellar Neuronopathy in a Patient Diagnosed with ALPS and Hypogammaglobulinemia
4. Stage‐related increase in PIM2 expression in mycosis fungoides.
5. Mutational landscape in Waldenström macroglobulinemia evaluated using a next-generation sequencing lymphoma panel in routine clinical practice.
6. Staphylococcus aureus Induces Signal Transducer and Activator of Transcription 5‒Dependent miR-155 Expression in Cutaneous T-Cell Lymphoma
7. Synthetic Nucleic Acid Antigens in Localized Scleroderma
8. LAG3 and TIGIT Expression on Tumor Infiltrating Lymphocytes in Cutaneous Melanoma.
9. ASO Visual Abstract: Colonic Stent as Bridge to Surgery for Malignant Obstruction Induces Gene Expressional Changes Associated with a More Aggressive Tumor Phenotype
10. LAG3 and TIGIT Expression on Tumor-Infiltrating Lymphocytes in Cutaneous Melanoma.
11. Danish Pathology Life Course (PATHOLIFE) cohort: a register based cohort extending upon a national tissue biobank
12. Gene Expression Linked to Reepithelialization of Human Skin Wounds
13. Combination Therapy with Ruxolitinib and Interferon in Newly Diagnosed Patients with Polycythemia Vera
14. Concomitant Inhibition of FASN and SREBP Provides a Promising Therapy for CTCL
15. The clinical course and life expectancy of patients with multiple myeloma who discontinue their first daratumumab‐containing line of therapy
16. The real-world outcomes of multiple myeloma patients treated with daratumumab
17. Notch1 as a potential therapeutic target in cutaneous T-cell lymphoma
18. Diagnostic Two-Gene Classifier in Early-Stage Mycosis Fungoides: A Retrospective Multicenter Study
19. Spatial expression of metallothionein, matrix metalloproteinase-1 and Ki-67 in human epidermal wounds treated with zinc and determined by quantitative immunohistochemistry: A randomised double-blind trial
20. Primary Cutaneous γδ T-Cell Lymphoma Positive for Both T-Cell Receptor γ and T-Cell Receptor β
21. The clinical course and life expectancy of patients with multiple myeloma who discontinue their first daratumumab‐containing line of therapy.
22. Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With CALR-Mutant Chronic Myeloproliferative Neoplasms
23. Detailed Long-Term Follow-Up of Patients Who Relapsed After the Nordic Mantle Cell Lymphoma Trials: MCL2 and MCL3
24. Fatal JC-virus Granular Cerebellar Neuronopathy associated with Autoimmune Lymphoproliferative Syndrome and Common Variable Immunodeficiency
25. Colonic Stent as Bridge to Surgery for Malignant Obstruction Induces Gene Expressional Changes Associated with a More Aggressive Tumor Phenotype.
26. Ruxolitinib and interferon-α2 combination therapy for patients with polycythemia vera or myelofibrosis: a phase II study
27. MicroRNAs in the Pathogenesis, Diagnosis, Prognosis and Targeted Treatment of Cutaneous T-Cell Lymphomas
28. Diagnostic 2-Gene Classifier in Early-Stage Mycosis Fungoides: A Retrospective Multicenter Study
29. Role of B-cells in Mycosis Fungoides.
30. Expression and function of Kv1.3 channel in malignant T cells in Sézary syndrome
31. TOX expression in patients with Mycosis fungoides- a potential diagnostic marker?
32. The Clinical Course and Life Expectancy of Patients with Multiple Myeloma Who Discontinue Their First Daratumumab-Containing Line of Therapy
33. Clinical and Histological Characteristics of Mycosis Fungoides and Sézary Syndrome: A Retrospective, Single-centre Study of 43 Patients from Eastern Denmark.
34. Orbital precursor B-lymphoblastic lymphoma involving the extraocular muscles in a 56-year-old male and a review of the literature.
35. The importance of Notch signaling in peripheral T-cell lymphomas
36. Different Immunological Phenotypes Associated with Preserved CD4+ T Cell Counts in HIV-Infected Controllers and Viremic Long Term Non-Progressors
37. The importance of Notch signaling in peripheral T-cell lymphomas.
38. Primary Cutaneous T-Cell Lymphoma Positive for Both T-Cell Receptor and T-Cell Receptor
39. Malignant T cells induce skin barrier defects through cytokine-mediated JAK/STAT signaling in cutaneous T-cell lymphoma
40. Combination Therapy with Ruxolitinib and Pegylated Interferon-alpha2a in Newly Diagnosed Patients with Polycythemia Vera.
41. [Lymphomas found by endoscopic screening for colorectal cancer].
42. Ubiquitin-specific protease 2 decreases p53-dependent apoptosis in cutaneous T-cell lymphoma.
43. [Molecular methods in diagnostic pathology].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.